Endometriosis Medication

Die medikamentöse Therapie von Endometriose verfolgt mehrere Ziele: akute Schmerzlinderung, Hemmung des Fortschreitens und – je nach Wunsch – auch die Förderung der Fruchtbarkeit. Zur Verfügung stehen verschiedene Wirkstoffklassen: von klassischen NSAR (z B. Ibuprofen) über Gestagene bis hin zu modernen GnRH-Antagonisten. Ergänzend gewinnen auch nicht-hormonelle Optionen wie das Medizinprodukt CANNEFF® Vaginalzäpfchen mit CBD und Hyaluronsäure an Bedeutung – insbesondere bei Schleimhautbeschwerden und Intimschmerzen. Welche Therapie geeignet ist, hängt vom individuellen Beschwerdebild, dem Zyklusverhalten, dem Kinderwunsch sowie von Nebenwirkungen und Vorerkrankungen ab. Eine dauerhafte Behandlung mit Hormonen sollte ärztlich begleitet werden – besonders im Hinblick auf Knochengesundheit und Langzeitwirkung. Schmerzmittel allein reichen oft nicht aus, können aber gezielt zur akuten Kontrolle eingesetzt werden. Neue Wirkstoffe wie Linzagolix oder Relugolix versprechen zudem eine verbesserte Steuerbarkeit hormoneller Therapien. Moderne Endometriose-Therapie bedeutet: Kombination statt Einzellösung – mit individuellen Optionen und sorgfältiger Abwägung. Eine enge Betreuung durch spezialisierte Zentren verbessert die Prognose nachhaltig.
Philip Schmiedhofer, MSc

Autor

Philip Schmiedhofer, MSc

Inhaltsverzeichnis

Medications for Endometriosis – an Overview

The drug therapy aims to relieve pain, slow the progression of the disease, and in some cases improve fertility.

Which medications help with endometriosis pain?

To relieve endometriosis pain, nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal agents are primarily used.

Hormone treatments for endometriosis: effects & side effects

Hormone preparations are a central pillar of drug therapy for endometriosis.

Using Painkillers Correctly for Endometriosis

Painkillers are part of the basic therapy for endometriosis, especially for acute symptoms.

New medications for endometriosis treatment in development

The treatment of endometriosis is continuously evolving.

Pill, progestins, GnRH – which one suits me?

The choice of the appropriate hormone preparation for the treatment of endometriosis depends on the individual symptoms, age, any contraindications, and especially the desire to have children.

Long-term medication therapy for endometriosis

Medication-based long-term therapy for endometriosis aims to permanently relieve symptoms and prevent relapses after surgery.

How long should one take medication for endometriosis?

The duration of drug treatment for endometriosis depends on the medication, the symptoms, and individual factors such as age or desire to have children.

Treating endometriosis without hormones – is it possible?

Yes, treatment of endometriosis without hormones is possible – especially to relieve pain and improve quality of life.

Medications for endometriosis – an overview

Drug therapy against endometriosis aims to relieve pain, slow disease progression, and in some cases improve fertility. It can be used alone or alongside surgery.

Find endometriosis medication

Drug class

Example preparations

Mechanism of action

Special features / limitations

NSAIDs

Ibuprofen, Naproxen

Inhibition of inflammatory mediators (prostaglandins)

Effective acutely, no disease-modifying effect

Progestins

Dienogest, Norethisterone

Estrogen antagonist, inhibits endometrial growth

Suitable for long-term therapy, often well tolerated

Combined contraceptives

Ethinylestradiol + Levonorgestrel

Ovulation inhibition, cycle control

Not for desire to conceive, increased risk of thrombosis

GnRH analogs

Leuprorelin, Triptorelin

Hormonal suppression state ("artificial menopause")

Limited therapy duration, add-back therapy necessary

GnRH antagonists

Elagolix, Linzagolix (e.g., Yselty®)

Rapid onset estrogen reduction

Newer substance class, well controllable, combination therapy recommended

SPRMs (Selective Progesterone Receptor Modulators)

UPA (not approved for endometriosis)

Blocking progesterone action

Research ongoing, no approval for endometriosis treatment

Note on long-term therapies:

Hormonal preparations are particularly suitable for long-term disease control, but therapy should be regularly monitored by a doctor – especially regarding bone health, cycle behavior, and side effects.

Important: In patients with vaginal mucosal involvement, dryness or painful symptoms in the intimate area, medical products such as CANNEFF® vaginal suppositories with CBD and hyaluronic acid can also be used. These relieve local symptoms and support mucosal regeneration.

Which medications help with endometriosis pain?

To relieve endometriosis pain, primarily nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal agents are used. While NSAIDs combat acute symptoms, hormonal preparations aim to inhibit the growth of endometriosis lesions and reduce pain in the long term. An individual selection is crucial depending on pain intensity, cycle dependence, and accompanying conditions.

To specifically relieve endometriosis pain, medications are used that affect both acute pain signals and the hormonal activity of the lesions. Selection depends on the pain type: cyclic, chronic, localized, or diffuse.

Differentiation by pain type and medication effect

Pain characteristics

Therapeutic approach

Suitable substance classes

Cyclic-inflammatory

Anti-inflammatory, prostaglandin inhibition

NSAIDs (e.g., naproxen, ibuprofen)

Hormone-dependent

Suppression of estrogen effect

Progestins, GnRH analogs/antagonists

Chronic-neuropathic

Modulation of pain memory

Off-label: Amitriptyline, Gabapentin (in consultation)

Local-vaginal

Symptom control for mucous membrane irritation

CANNEFF® vaginal suppositories with CBD + hyaluronic acid

Not all pain in endometriosis is hormone-related. In long-term courses, patients can develop Centralized pain (chronic pain memory) develop that do not respond sufficiently to NSAIDs or hormone therapy. In such cases, adjusting medication combined with pain psychotherapy is advisable.

Hormonal preparations for endometriosis: effects & side effects

Hormonal preparations are a central pillar of medical endometriosis therapy. They work by altering the hormonal environment to inhibit the growth of endometriosis lesions and reduce inflammation. The goal is artificially induced estrogen suppression – with different mechanisms of action and side effect profiles.

Endometriosis medication that works

Overview of common hormonal preparations for endometriosis

Drug class

Mode of action

Example preparations

Common side effects

Progestins

Continuous use suppresses ovulation, lowers estrogen

Dienogest, Norethisterone

Breakthrough bleeding, weight gain, mood swings

Combined oral contraceptives

Cycle suppression through estrogen-progestin combination

Ethinylestradiol + Levonorgestrel

Breast tenderness, nausea, slightly increased risk of thrombosis

GnRH analogs

Blockade of the pituitary hormone axis → "artificial menopause"

Leuprorelin, Buserelin

Hot flashes, bone density loss, depressive mood

GnRH antagonists

Direct inhibition of GnRH receptors

Relugolix, Linzagolix

Less severe side effects but possibly expensive

Intrauterine systems

Local hormone release into the uterus

Levonorgestrel IUD (e.g., Mirena®)

Spotting, irregular cycles at the beginning

What to Consider When Choosing?

  • Progestins are considered well tolerated for long-term therapy, especially dienogest.
  • GnRH analogs/antagonists are used in severe or therapy-resistant cases – preferably with "add-back therapy" (e.g., low-dose estradiol) to minimize side effects.
  • Combined Preparations are especially suitable when contraception is also needed.
  • In case of Desire to Have Children are contraindicated with hormone preparations, as they temporarily inhibit fertility.

Proper Use of Painkillers in Endometriosis

Painkillers are part of the basic therapy for endometriosis, especially for acute symptoms. They relieve the symptoms but do not address the cause of the disease. Targeted, responsible use is therefore important – ideally embedded in a holistic treatment concept.

Drug group

Examples

Effect

Usage recommendation

NSAIDs (nonsteroidal anti-inflammatory drugs)

Ibuprofen, Naproxen, Diclofenac

Anti-inflammatory, pain-relieving

First choice for mild to moderate pain; take as early as possible in the cycle

COX-2 inhibitors

Celecoxib, Etoricoxib

Selective anti-inflammatory, gentler on the stomach

Alternative for stomach problems caused by NSAIDs

Paracetamol

Paracetamol

Pure pain reduction without anti-inflammatory effect

Less effective; rather for intolerance to other drugs

Metamizole (prescription required)

Novalgin

Strong pain relief, also antispasmodic

For severe symptoms under medical supervision

Opioids (only in exceptional cases)

Tramadol, Tilidine

Strong analgesic, centrally acting

Short-term use for therapy-resistant pain; not for long-term use

Instructions for use

  • Take Early: NSAIDs work better if taken before the pain starts.
  • Do Not Use Permanently: Chronic use can lead to stomach, liver, and kidney damage.
  • Dosage under Medical Supervision: If necessary, rotation of active ingredients can be done to minimize side effects.
  • Combine with Hormone Therapy: Painkillers alone are often not enough – they should be part of an overall treatment plan.

New Drugs for Endometriosis Treatment in Development

The treatment of endometriosis is continuously evolving. While classic hormone therapies are often effective but not free of side effects, new drugs specifically target the underlying mechanisms of the disease. The goal is to improve quality of life – with the best possible tolerability and minimal impact on fertility.

Active ingredient / approach

Mechanism of action

Development status

Special features

Linzagolix (Yselty®)

GnRH antagonist: specifically lowers estrogen levels

EU approval 2024

Oral intake, individually dosable

Relugolix

GnRH antagonist, similar to linzagolix

In studies for endometriosis

Already approved for uterine fibroids

BAY2395840 (Bayer)

Antibody against chemerin receptor

Clinical phase I

Specifically inhibits inflammatory processes

4-Hydroxyindole (experimental)

Microbiome metabolite: reduces lesions in animal model

Preclinical research

Microbiome approach for future therapy

Epigenetic modulators

Regulation of pathological gene expression

Basic research

Prospective for personalized therapies

CANNEFF® vaginal suppositories

CBD + hyaluronic acid: anti-inflammatory, pain-relieving

Medical device – clinical study on endometriosis

Hormone-free, already approved for mucosal irritation & pain

Immunomodulators (e.g., anti-TNF)

Targeted inhibition of pro-inflammatory cytokines

Early studies

New option for immunological involvement

Pill, progestins, GnRH – what suits me?

The choice of the appropriate hormonal preparation for the treatment of endometriosis depends on the individual symptoms, age, possible contraindications, and especially the desire for children. The goal is to inhibit the effect of estrogen to stop the growth of endometriosis lesions and relieve pain.

Preparation

Mode of action

Especially suitable for

Combined pill

Estrogen + progestin – inhibits ovulation and lining buildup

Women without desire for children with regular cycles

Progestin monotherapy

Progestin only – permanent hormonal suppression

Women with increased risk of thrombosis or estrogen intolerance

GnRH analogs

Profound estrogen suppression (artificial menopause)

Severe endometriosis without current desire for children

GnRH antagonists

Rapid, controlled estrogen reduction

Modern option for severe symptoms

Long-term drug therapy for endometriosis

Long-term drug therapy for endometriosis aims to relieve symptoms permanently and prevent relapses after surgery. Mainly progestins or low-dose GnRH antagonists are used. They suppress the hormonal environment that promotes the growth of endometriosis lesions.

Endometriosis medication doctor

Long-term therapies are effective but carry risks of side effects such as cycle disturbances, bone density loss (with GnRH), or mood swings. Regular medical check-ups are therefore essential. The treatment duration is individually based on symptom progression, tolerance, and desire to have children.

How long should you take medication for endometriosis?

The duration of a drug treatment for endometriosis depends on the medication, symptoms, and individual factors such as age or desire to have children. Usually, hormone therapy is used for several months to years – as long as it is well tolerated and effective.

With GnRH analogs, the treatment duration is usually limited to 6 months, often with add-back therapy. Progestins or the birth control pill can be taken long-term, as can non-hormonal painkillers as needed. Regular medical monitoring is essential.

Treating endometriosis without hormones – is it possible?

Yes, a treatment for endometriosis without hormones is possible – especially to relieve pain and improve quality of life. However, it does not replace causal therapy for severe hormone-dependent lesions. Non-hormonal approaches are particularly considered when hormonal therapies are not tolerated or if there is a desire to have children.

Overview of non-hormonal treatment options:

Type of therapy

Area of application

NSAIDs (e.g., ibuprofen, naproxen)

Acute pain relief for menstrual cramps

Medical products like CANNEFF® suppositories

Local anti-inflammatory treatment and pain relief for mucous membrane irritation (rectal or vaginal)

Physiotherapy

Pelvic floor tension, promoting movement

Nutritional therapy

Anti-inflammatory diet, histamine or gluten reduction

Complementary medicine

Acupuncture, yoga, TENS, osteopathy

Psychological support

Pain processing, dealing with chronic illness

 

Back to the blog
Philip Schmiedhofer, MSc

Philip Schmiedhofer, MSc

Medical Technician & Neuroscientist

Philip is the managing director and co-founder of cannmedic GmbH. With a degree in medical engineering and molecular biology, specializing in neuroscience and focusing on cannabinoids, he is recognized as an expert in the application of cannabinoids in medicine. As a medical device consultant, he leads the sales of cannmedic and offers specialized advice to medical professionals. His expertise includes the development and sales of cannabinoid-based products. In the field of research, he participates in significant basic research at the Center for Brain Research at the Medical University of Vienna. As co-founder and current managing director of cannhelp GmbH, a pioneer in the CBD sector, he has many years of entrepreneurial experience. Furthermore, he maintains an extensive network in the industry and advises internationally operating companies in the field of medical cannabinoids.